A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
Status:
RECRUITING
Trial end date:
2025-10-08
Target enrollment:
Participant gender:
Summary
This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.